ArticleFrontiers in immunology2018

A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the

Laure Yatime et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.